Discover Asian Undervalued Small Caps With Insider Buying In June 2026

Simply Wall St.06-17

Amidst a backdrop of geopolitical tensions and inflationary pressures, Asian markets have shown resilience with mixed performances across key indices. As small-cap stocks in the region navigate these ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2644795896?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-06-17 06:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644795896","market":"us","top_or_hot":-1,"title":"Discover Asian Undervalued Small Caps With Insider Buying In June 2026","media":"Simply Wall St.","content":"<div>\n<p>Amidst a backdrop of geopolitical tensions and inflationary pressures, Asian markets have shown resilience with mixed performances across key indices. As small-cap stocks in the region navigate these ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/discover-asian-undervalued-small-caps-with-insider-buying-in\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Discover Asian Undervalued Small Caps With Insider Buying In June 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDiscover Asian Undervalued Small Caps With Insider Buying In June 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-17 06:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/discover-asian-undervalued-small-caps-with-insider-buying-in><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amidst a backdrop of geopolitical tensions and inflationary pressures, Asian markets have shown resilience with mixed performances across key indices. As small-cap stocks in the region navigate these ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/discover-asian-undervalued-small-caps-with-insider-buying-in\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FCL.AU","symbol_name":"FINEOS CORP HOLDINGS PLC-CDI","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/discover-asian-undervalued-small-caps-with-insider-buying-in","article_id":"2644795896","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/discover-asian-undervalued-small-caps-with-insider-buying-in","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2644795896","pubTimestamp":1781647632,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Amidst a backdrop of geopolitical tensions and inflationary pressures, Asian markets have shown resilience with mixed performances across key indices. As small-cap stocks in the region navigate these volatile conditions, identifying opportunities often involves looking for companies with strong fundamentals and insider confidence, which can indicate potential value in an uncertain market environment.","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"FCL.AU":"FINEOS CORP HOLDINGS PLC-CDI","LU1861217088.USD":"贝莱德金融科技A2","DFS":"发现金融","LU0106831901.USD":"贝莱德世界金融基金A2","BK7016":"应用软件","BK4166":"消费信贷","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","BK4588":"碎股","BK7503":"科技股","BK4585":"ETF&股票定投概念","LU1861220207.SGD":"Blackrock FinTech A2 SGD-H","BVS.AU":"BRAVURA SOLUTIONS LTD","LU2360107671.USD":"BGF FINTECH \"A4\" (USD) INC"},"translate_title":"2026年6月通过内部购买发现亚洲被低估的小盘股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FCL.AU":1,"BVS.AU":1,"DFS":1.5},"content_text":"Amidst a backdrop of geopolitical tensions and inflationary pressures, Asian markets have shown resilience with mixed performances across key indices. As small-cap stocks in the region navigate these volatile conditions, identifying opportunities often involves looking for companies with strong fundamentals and insider confidence, which can indicate potential value in an uncertain market environment.AdvertisementTop 10 Undervalued Small Caps With Insider Buying In AsiaNamePEPSDiscount to Fair ValueValue RatingCenturion10.9x3.7x32.95%★★★★★★Security Bank4.2x0.9x28.33%★★★★★★FINEOS Corporation Holdings480.0x3.3x23.21%★★★★★☆East West Banking3.0x0.8x30.54%★★★★☆☆Hung Hing Printing GroupNA0.3x45.62%★★★★☆☆Dicker Data25.1x0.8x-29.94%★★★☆☆☆Shoucheng Holdings46.2x10.0x46.20%★★★☆☆☆Integral Diagnostics55.0x1.0x49.77%★★★☆☆☆PSC11.5x0.5x47.98%★★★☆☆☆SiteMinderNA4.3x21.90%★★★☆☆☆ Click here to see the full list of 61 stocks from our Undervalued Asian Small Caps With Insider Buying screener.\n    Let's take a closer look at a couple of our picks from the screened companies.Bravura Solutions (ASX:BVS)Simply Wall St Value Rating: ★★★☆☆☆Overview: Bravura Solutions is a software company that provides wealth management and funds administration services, with a market cap of A$0.38 billion.Operations: The company generates revenue primarily from the EMEA region, contributing A$198.08 million, followed by APAC at A$73.12 million. Over recent periods, gross profit margin has shown variability, reaching 34.10% in December 2025 after a low of 15.91% in June 2023. Operating expenses have fluctuated significantly, impacting net income margins which have ranged from -112.22% to 28.40%.PE: 23.9xBravura Solutions, a player in the financial software industry, is navigating changes with insider confidence reflected through recent share purchases. Their profit margin has dipped from 28.2% to 14.3% over the past year, yet earnings are projected to grow annually by 8.3%. The company operates with higher-risk funding due to reliance on external borrowing rather than customer deposits. Recent leadership shifts include the departure of CFO Neil Montford and new board member Colin Greenhill joining as executive director.Click here and access our complete valuation analysis report to understand the dynamics of Bravura Solutions.Evaluate Bravura Solutions' historical performance by accessing our past performance report.ASX:BVS Share price vs Value as at Jun 2026FINEOS Corporation Holdings (ASX:FCL)Simply Wall St Value Rating: ★★★★★☆Overview: FINEOS Corporation Holdings is a software and programming company specializing in providing core systems for life, accident, and health insurance carriers with a market cap of €0.24 billion.Operations: FINEOS Corporation Holdings generates revenue primarily from its Software & Programming segment, with a recent figure of €138.43 million. The company's gross profit margin has shown an upward trend, reaching 76.21% as of the latest period. Operating expenses are significant, largely driven by research and development costs, which were €57.03 million in the most recent period.PE: 480.0xFINEOS Corporation Holdings, a player in the insurance tech sector, is gaining traction through strategic partnerships and client expansions. Recent collaborations with OneAmerica Financial and Opifiny Corp enhance its market presence, promising faster claims processing and improved customer experiences. The company's growth prospects are bolstered by insider confidence shown through share purchases in early 2026. With earnings forecasted to grow annually by 39%, FINEOS presents a compelling opportunity for those eyeing dynamic small companies in Asia's insurance technology landscape.Navigate through the intricacies of FINEOS Corporation Holdings with our comprehensive valuation report here.Review our historical performance report to gain insights into FINEOS Corporation Holdings''s past performance.ASX:FCL Share price vs Value as at Jun 2026Shanghai Haohai Biological Technology (SEHK:6826)Simply Wall St Value Rating: ★★★☆☆☆Overview: Shanghai Haohai Biological Technology is engaged in the production and sale of biologics, specifically focusing on medical hyaluronic acid, with a market cap of CN¥9.35 billion.Operations: The company generates revenue primarily from the production and sale of biologics, particularly medical hyaluronic acid. Over recent periods, the gross profit margin has shown a decreasing trend, reaching 68.29% by mid-2026.PE: 13.7xShanghai Haohai Biological Technology is navigating a challenging period with a dip in Q1 2026 sales to CNY 571.44 million from CNY 618.54 million the previous year, and net income dropping to CNY 73.56 million from CNY 90.31 million. Despite this, insider confidence is evident as insiders have shown interest in purchasing shares over recent months, signaling potential optimism about future growth prospects despite current financial hurdles. The company recently affirmed a dividend of RMB 0.6 per share for the fiscal year ending December 2025, providing some return to shareholders amidst these changes.Take a closer look at Shanghai Haohai Biological Technology's potential here in our valuation report.Gain insights into Shanghai Haohai Biological Technology's historical performance by reviewing our past performance report.SEHK:6826 Ownership Breakdown as at Jun 2026Key TakeawaysGain an insight into the universe of 61 Undervalued Asian Small Caps With Insider Buying by clicking here.Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.Want To Explore Some Alternatives?Explore high-performing small cap companies that haven't yet garnered significant analyst attention.Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.Find companies with promising cash flow potential yet trading below their fair value.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644795896","isCrawlerRequest":true}